V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000870 | 230000515 | 1.75 | 86.3 | Neo-adjuvant (N) | 2014-03-11 | 2014-03-22 | CARBOPLATIN + PACLITAXEL | 02 | N | 230019658 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 230000871 | 230000516 | 1.73 | 84.9 | Not known (9) | 2016-07-16 | 2016-07-21 | Capecitabine | N | N | 230019683 | CISPLATIN + PEMETREXED |
| 230000872 | 230000517 | 1.68 | 64 | null | 2018-07-31 | 2018-08-06 | Capecitabine + Oxaliplatin 14day | 02 | null | 230019689 | HYDROXYCARBAMIDE |
| 230000873 | 230000518 | null | 57.2 | Palliative (P) | 2016-08-15 | 2016-09-12 | Oxaliplatin + Modified de Gramont | N | null | 230019726 | TRIAL |
| 230000874 | 230000518 | 1.84 | 84 | Adjuvant (A) | 2016-05-21 | 2016-06-16 | Capecitabine + Oxaliplatin 21day | N | N | 230019726 | PACLITAXEL |
| 230000875 | 230000518 | 1.62 | 62.3 | Curative (C) | 2016-01-15 | 2016-01-22 | Cisplatin + Doxorubicin | N | N | 230019726 | CAPECITABINE + OXALIPLATIN |
| 230000876 | 230000519 | 1.69 | 0 | Curative (C) | 2016-02-12 | 2016-03-01 | Fluorouracil+Mitomycin+RT (Bladder) | N | N | 230020193 | IRINOTECAN + MDG |
| 230000877 | 230000520 | 1.69 | 78.6 | Palliative (P) | 2017-06-22 | 2017-06-22 | Enzalutamide | N | N | 230020347 | CISPLATIN + FLUOROURACIL |
| 230000878 | 230000520 | 1.61 | 70 | Adjuvant (A) | 2017-07-14 | 2018-06-09 | Folfirinox | 02 | N | 230020347 | SORAFENIB |
| 230000879 | 230000521 | 1.7 | 72 | Adjuvant (A) | 2016-04-29 | 2016-05-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 230020468 | CISPLATIN + FLUOROURACIL |
| 230000880 | 230000522 | 1.5 | null | Curative (C) | 2015-07-06 | 2015-07-12 | CARBOPLATIN | N | Y | 230020493 | CAPECITABINE + OXALIPLATIN |
| 230000881 | 230000523 | 1.57 | 67.1 | Curative (C) | 2014-11-16 | 2014-12-12 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 230020504 | CISPLATIN + RT |
| 230000882 | 230000524 | 1.49 | 53.3 | Curative (C) | 2018-03-01 | 2018-03-02 | Trastuzumab Subcutaneous | 02 | N | 230020543 | OXALIPLATIN + RALTITREXED |
| 230000883 | 230000525 | 1.68 | 57.6 | null | 2017-08-07 | 2017-08-17 | Capecitabine | N | N | 230020592 | ESPAC TRIAL |
| 230000884 | 230001248 | 1.56 | 62.7 | Curative (C) | 2014-02-04 | 2014-02-05 | Fluorouracil + Folinic Acid Weekly | 02 | Y | 230020619 | PACLITAXEL |
| 230000885 | 230001248 | 1.63 | 51.7 | Palliative (P) | 2018-08-27 | 2018-09-04 | CAPECITABINE + OXALIPLATIN | N | null | 230020619 | CHOP R |
| 230000886 | 230001248 | 1.75 | 62 | Curative (C) | 2018-05-15 | 2018-06-06 | Irinotecan + Modified De Gramont | N | N | 230020619 | CAPECITABINE |
| 230000887 | 230001248 | 1.63 | 64.2 | Palliative (P) | null | 2017-01-04 | Carboplatin + Etoposide iv&po | null | N | 230020619 | CISPLATIN + DOCETAXEL |
| 230000888 | 230000526 | 1.73 | 84 | Palliative (P) | 2017-11-04 | 2017-11-05 | AFATINIB | 02 | N | 230020898 | CARBOPLATIN |
| 230000889 | 230001249 | 0 | 52 | Curative (C) | 2016-07-19 | 2016-07-22 | FLUOROURACIL + OXALIPLATIN | 02 | N | 230020962 | CISPLATIN + RT |
| 230000890 | 230001539 | null | 77 | Curative (C) | 2014-11-07 | 2014-11-28 | Sorafenib | N | Y | 230021306 | CVP R |
| 230000891 | 230000527 | null | 71.4 | Disease modification (D) | 2017-03-22 | 2017-03-28 | Oxaliplatin + Modified de Gramont | 2 | N | 230021625 | FLUDARABINE |
| 230000892 | 230000528 | 1.62 | 145.8 | Not known (9) | 2019-01-12 | 2019-01-13 | BOSUTINIB | N | N | 230021656 | SORAFENIB |
| 230000893 | 230000529 | 1.6 | 52.5 | null | 2018-03-22 | 2018-04-02 | FOXFIRE TRIAL | N | null | 230021760 | NAB-PACLITAXEL |
| 230000894 | 230001250 | 1.76 | 77.2 | Adjuvant (A) | 2014-07-18 | 2014-07-24 | METHOTREXATE | 1 | N | 230021833 | CARBOPLATIN + PACLITAXEL |
| 230000895 | 230000530 | 1.55 | 57.4 | Curative (C) | 2016-03-16 | 2016-03-16 | VANDETANIB | 02 | null | 230021849 | CARBOPLATIN |
| 230000896 | 230000530 | 1.74 | 80 | Palliative (P) | 2018-11-29 | 2018-12-24 | Capecitabine 35days + RT | 02 | N | 230021849 | CAPECITABINE |
| 230000897 | 230000530 | 1.76 | null | Neo-adjuvant (N) | 2014-04-20 | 2014-05-17 | Capecitabine | N | null | 230021849 | OLAPARIB |
| 230000898 | 230000531 | null | null | Neo-adjuvant (N) | 2016-02-07 | 2016-02-15 | Paclitaxel (2 or 3 weekly) | N | Y | 230022218 | TRIAL |
| 230000899 | 230000532 | 1.64 | 52 | Palliative (P) | 2017-11-29 | 2017-12-21 | Capecitabine | N | N | 230022499 | TEMOZOLOMIDE |
| 230000900 | 230000533 | 1.51 | 60.3 | Curative (C) | null | 2016-02-14 | FEC + DOCETAXEL | N | N | 230022554 | HYDROXYCARBAMIDE |
| 230000901 | 230000534 | 1.74 | 75.05 | Adjuvant (A) | 2013-04-04 | 2013-04-12 | Capecitabine | N | N | 230022558 | TRIAL |
| 230000902 | 230000535 | 1.62 | 42 | Curative (C) | 2017-11-12 | 2017-11-23 | Oxaliplatin + Modified de Gramont | 02 | N | 230023043 | CARBOPLATIN + PACLITAXEL |
| 230000903 | 230000535 | 1.66 | 96.7 | Curative (C) | 2013-09-13 | 2013-09-20 | Carboplatin + Vinorelbine Oral | 02 | N | 230023043 | CAPECITABINE |
| 230000904 | 230000536 | 1.57 | 60.7 | Neo-adjuvant (N) | 2016-08-06 | 2016-08-18 | GEMCITABINE + NAB PACLITAXEL | 02 | N | 230023262 | GEMCARBO |
| 230000905 | 230001253 | 0 | 90 | Adjuvant (A) | 2016-11-07 | 2016-11-07 | Carboplatin + Pemetrexed | 02 | N | 230023324 | FLUOROURACIL + MITOMYCIN + RT |
| 230000906 | 230001541 | 1.85 | 110 | Palliative (P) | 2017-09-07 | 2017-09-07 | CISPLATIN + RT | N | N | 230023333 | LENVATINIB |
| 230000907 | 230001670 | 1.72 | 56.7 | Adjuvant (A) | 2015-07-06 | 2015-07-06 | CHOP R - 21 days | null | null | 230023380 | FEC |
| 230000908 | 230001713 | 1.61 | 95.2 | Neo-adjuvant (N) | 2016-03-23 | 2016-04-04 | Capecitabine + Oxaliplatin 21day | N | N | 230023447 | CISPLATIN + RT |
| 230000909 | 230001713 | 1.82 | null | Adjuvant (A) | 2018-01-30 | 2018-02-20 | Temozolomide + RT | N | null | 230023447 | VANDETANIB |
| 230000910 | 230000537 | 1.58 | 93.6 | Adjuvant (A) | 2017-12-29 | 2018-01-05 | Oxaliplatin + Modified de Gramont | null | N | 230023578 | CABOZANTINIB |
| 230000911 | 230001254 | 1.51 | 75 | Palliative (P) | 2013-07-22 | 2013-08-17 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 230023598 | CISPLATIN + RT |
| 230000912 | 230000538 | 0 | 66.6 | Adjuvant (A) | null | 2016-02-14 | FLUOROURACIL | 1 | N | 230023706 | CARBOPLATIN + PEMETREXED |
| 230000913 | 230001255 | 1.86 | 68 | Disease modification (D) | 2017-12-23 | 2017-12-30 | Oxaliplatin + Modified de Gramont | 02 | N | 230023710 | GEMCARBO |
| 230000914 | 230001542 | 1.7 | 100.1 | Adjuvant (A) | 2017-02-15 | 2017-02-25 | Capecitabine + Mitomycin | 02 | N | 230023720 | CVP R |
| 230000915 | 230000539 | 1.65 | 82.2 | Neo-adjuvant (N) | 2015-03-05 | 2015-04-11 | CAPECITABINE + OXALIPLATIN | N | N | 230023727 | FLUOROURACIL + MITOMYCIN + RT |
| 230000916 | 230001256 | 1.7 | 61 | Curative (C) | 2018-01-06 | 2018-01-16 | FEC 60 or 75 | N | Y | 230023741 | BENDAMUSTINE + RITUXIMAB |
| 230000917 | 230001256 | 1.6 | 89 | Adjuvant (A) | 2013-08-07 | 2013-08-18 | Capecitabine | 02 | N | 230023741 | CHLORAMBUCIL + RITUXIMAB |
| 230000918 | 230001256 | 1.6 | 51.2 | Adjuvant (A) | null | 2013-12-29 | IVA | N | N | 230023741 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 230000919 | 230000540 | 1.61 | 61.3 | Adjuvant (A) | 2018-12-27 | 2019-01-11 | Trastuzumab Subcutaneous | N | N | 230024102 | PACLITAXEL |